Plby Group Inc vs 22nd Century Group Inc — how do they compare? Plby Group Inc trades at $0.98 (market cap $118.21M), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Plby Group Inc is far larger — about 190.1× 22nd Century Group Inc's market cap, and Plby Group Inc is more actively traded (919,783 versus 45,625). Which is the better fit depends on your goals — on Pluang, investors hold Plby Group Inc for 24 Days and 22nd Century Group Inc for 32 Days on average.
| PLBY | XXII | |
|---|---|---|
Market Cap | $118.21M | $621.67K |
Volume | 919,783 | 45,625 |
Sector | Consumer Cyclical | Consumer Staples |
52-Week High | $2.71 | $483.00 |
52-Week Low | $0.99 | $0.80 |
Typical Hold Time | 24 Days | 32 Days |
Enterprise Value | $263.80M | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
PLBY trades at $0.9867, down 3.26% today, amid bearish technical signals but with improving fundamentals. Recent earnings show a Q2 2026 beat, and cash flow turned positive in 2025. The company is expanding leadership to drive growth, yet faces high debt and negative equity. Analyst consensus is 75% buy, reflecting optimism on turnaround efforts.
Outlook hinges on execution of growth initiatives and debt management. Opportunities include brand licensing expansion and media strategy, but risks from high leverage and competitive pressures persist. Investors should weigh improving operational trends against financial stability concerns.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →